|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02637 HAIXI PHARMA
Nominal 
184.200 -8.500 (-4.411%) Ranking Overview
Ranking based on 2 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 255.00 RMB (cts) | |
| Net Profit | 177.03 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 193.20 | 245.50 | -- | 198.40 | 188.00 | |
| 2027 | 220.35 | 280.00 | -- | 222.70 | 218.00 | |
| 2028 | 248.90 | 316.00 | -- | 250.80 | 247.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 188.00 | 239.00 | -- | SWS | Buy | 298.28 | 23/04/2026 | |
| 2026 | 198.40 | 252.00 | -- | CMB INT'L SEC | Buy | 280.00 | 18/09/2026 | |
| 2027 | 218.00 | 277.00 | -- | SWS | -- | -- | 23/04/2026 | |
| 2027 | 222.70 | 283.00 | -- | CMB INT'L SEC | -- | -- | 18/09/2026 | |
| 2028 | 247.00 | 313.00 | -- | SWS | -- | -- | 23/04/2026 | |
| 2028 | 250.80 | 319.00 | -- | CMB INT'L SEC | -- | -- | 18/09/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 21/09/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 81,049 |
| %Change | -24.820% |
| EPS / (LPS) | RMB 1.030 |
| NBV Per Share (¥) | RMB 21.208 |